Loading…
Lobbying Spend
—
Filings
59
Firms Hired
1
Active Period
2011–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Outreach re: TRIPS waiver PBM issues H.R.6283 - Delinking Revenue from Unfair Gouging (DRUG) Act
Client expense: — · Firm income: $75,000
Matched citations: H.R.6283
Lower Costs, More Cures Act of 2021
2022 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing H.R.19 (McMorris Rodgers) - Lower Costs, More Cures Act of 2021 Issues related to drug manufacturing Outreach regarding efforts to improve mental health services
Client expense: — · Firm income: $75,000
Matched citations: H.R.19
Lower Costs, More Cures Act of 2021
2021 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing H.R.19 (McMorris Rodgers) - Lower Costs, More Cures Act of 2021 Reconciliation
Client expense: — · Firm income: $75,000
Matched citations: H.R.19
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Issues related to Covid-19 and H.R.1319 (Yarmuth) - American Rescue Plan Act
Client expense: — · Firm income: $75,000
Matched citations: H.R.1319
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021
Client expense: — · Firm income: $75,000
Matched citations: H.R.133
Drug Pricing Issues related to COVID-19: H.R.748 - CARES Act Drug pricing; most-favored nations rule
Client expense: — · Firm income: $75,000
Matched citations: H.R.748
Patient Protection and Affordable Care Enhancement Act
2020 · second_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing Issues related to COVID-19: H.R.748 - CARES Act H.R.1425 (Craig) - Patient Protection & Affordable Care Enhancement Act
Client expense: — · Firm income: $75,000
Matched citations: H.R.1425
Drug Pricing Issues related to COVID-19: H.R.748 - CARES Act H.R.1425 (Craig) - Patient Protection & Affordable Care Enhancement Act
Client expense: — · Firm income: $75,000
Matched citations: H.R.748
Families First Coronavirus Response Act
2020 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing Issues related to COVID-19: H.R.6201 - Families First Coronavirus Response Act; H.R.748 - CARES Act Notice of Benefit and Payment Parameters (NBPP) Letter to HHS
Client expense: — · Firm income: $75,000
Matched citations: H.R.6201
Drug Pricing Issues related to COVID-19: H.R.6201 - Families First Coronavirus Response Act; H.R.748 - CARES Act Notice of Benefit and Payment Parameters (NBPP) Letter to HHS
Client expense: — · Firm income: $75,000
Matched citations: H.R.748
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing H.R.3 (Pallone) - Lower Drug Costs Now Act of 2019
Client expense: — · Firm income: $50,000
Matched citations: H.R.3
Elijah E. Cummings Lower Drug Costs Now Act
2019 · third_quarter · Firm: THE DUBERSTEIN GROUP INC.
Drug Pricing H.R.3 (Pallone) - Lower Drug Costs Now Act of 2019
Client expense: — · Firm income: $75,000
Matched citations: H.R.3
Consolidated Appropriations Act, 2018
2018 · second_quarter · Firm: THE DUBERSTEIN GROUP INC.
Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018 Drug Pricing Pay-fors.
Client expense: — · Firm income: $75,000
Matched citations: HR 1625
Bipartisan Budget Act of 2018
2018 · second_quarter · Firm: THE DUBERSTEIN GROUP INC.
Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018 Drug Pricing Pay-fors.
Client expense: — · Firm income: $75,000
Matched citations: HR 1892
Consolidated Appropriations Act, 2018
2018 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018 Pay-fors.
Client expense: — · Firm income: $75,000
Matched citations: HR 1625
Consolidated Appropriations Act, 2018
2018 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Pay-Fors. Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018
Client expense: — · Firm income: $75,000
Matched citations: HR 1625
Bipartisan Budget Act of 2018
2018 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018 Pay-fors.
Client expense: — · Firm income: $75,000
Matched citations: HR 1892
Bipartisan Budget Act of 2018
2018 · first_quarter · Firm: THE DUBERSTEIN GROUP INC.
Pay-Fors. Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018
Client expense: — · Firm income: $75,000
Matched citations: HR 1892
Continuing Appropriations Amendments Act, 2018
2017 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
Children's Health Insurance Program (CHIP) Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1301
Protecting Seniors Access to Medicare Act
2017 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
IPAB Disapproval Resolution: S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017 IPAB Repeal: H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: H.R.849
Protecting Seniors' Access to Medicare Act of 2017
2017 · fourth_quarter · Firm: THE DUBERSTEIN GROUP INC.
IPAB Disapproval Resolution: S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017 IPAB Repeal: H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017
Client expense: — · Firm income: $60,000
Matched citations: S.260
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
2017 · third_quarter · Firm: THE DUBERSTEIN GROUP INC.
IPAB Disapproval Resolution: -S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017. -HJ Res. 51 (Roe/Ruiz) - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act. -H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017
Client expense: — · Firm income: $45,000
Matched citations: HJ Res. 51
Continuing Appropriations Amendments Act, 2018
2017 · third_quarter · Firm: THE DUBERSTEIN GROUP INC.
Health Care Reform: H.R.1628 - Better Care Reconciliation Act of 2017. Drug Re-importation: S.469 (Sanders) - Affordable and Safe Prescription Drug Importation Act, H.R.1301 - Department of Defense Appropriations Act, 2017. Prescription Drug User Fee Act (PDUFA) - H.R.2430 - FDA Reauthorization Act of 2017 Children's Health Insurance Program. Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.
Client expense: — · Firm income: $45,000
Matched citations: H.R.1301
American Health Care Act of 2017
2017 · third_quarter · Firm: THE DUBERSTEIN GROUP INC.
Health Care Reform: H.R.1628 - Better Care Reconciliation Act of 2017. Drug Re-importation: S.469 (Sanders) - Affordable and Safe Prescription Drug Importation Act, H.R.1301 - Department of Defense Appropriations Act, 2017. Prescription Drug User Fee Act (PDUFA) - H.R.2430 - FDA Reauthorization Act of 2017 Children's Health Insurance Program. Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.
Client expense: — · Firm income: $45,000
Matched citations: H.R.1628
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: THE DUBERSTEIN GROUP INC.
Health Care Reform: H.R.1628 - Better Care Reconciliation Act of 2017. Drug Re-importation: S.469 (Sanders) - Affordable and Safe Prescription Drug Importation Act, H.R.1301 - Department of Defense Appropriations Act, 2017. Prescription Drug User Fee Act (PDUFA) - H.R.2430 - FDA Reauthorization Act of 2017 Children's Health Insurance Program. Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.
Client expense: — · Firm income: $45,000
Matched citations: H.R.2430
Source: Senate LDA